Immunotherapy drug becomes first therapy approved by FDA for rare skin cancer
Sunday, March 26, 2017 - 10:31
in Health & Medicine
The U.S. Food and Drug Administration has granted accelerated approval to the checkpoint inhibitor Bavencio (avelumab) for the treatment of patients with metastatic Merkel cell carcinoma.